NextPlat Corp (NASDAQ:NXPL – Get Free Report) was the recipient of a significant decrease in short interest in November. As of November 15th, there was short interest totalling 17,700 shares, a decrease of 20.3% from the October 31st total of 22,200 shares. Based on an average daily volume of 43,100 shares, the short-interest ratio is currently 0.4 days. Approximately 0.1% of the shares of the company are sold short.
Institutional Trading of NextPlat
A hedge fund recently bought a new stake in NextPlat stock. Omnia Family Wealth LLC acquired a new position in NextPlat Corp (NASDAQ:NXPL – Free Report) in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 93,429 shares of the company’s stock, valued at approximately $132,000. Omnia Family Wealth LLC owned approximately 0.49% of NextPlat as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors and hedge funds own 1.30% of the company’s stock.
NextPlat Price Performance
Shares of NXPL opened at $0.79 on Monday. The company has a current ratio of 3.70, a quick ratio of 3.04 and a debt-to-equity ratio of 0.04. The stock’s 50 day moving average is $1.13 and its two-hundred day moving average is $1.15. NextPlat has a twelve month low of $0.75 and a twelve month high of $2.68. The firm has a market capitalization of $20.57 million, a PE ratio of -1.16 and a beta of 0.92.
NextPlat Company Profile
NextPlat Corp operates as a healthcare and e-commerce company in Europe, North America, South America, the Asia and Pacific, and Africa. The company operates full-service retail specialty services pharmacies that provides prescription pharmaceuticals prescription pharmaceuticals, third-party administration, risk and data management services, compounded medications, tele-pharmacy services, anti-retroviral medications, medication therapy management, contracted pharmacy services, and health practice risk management to healthcare organizations and providers, as well as supplies prescription medications to long-term care facilities.
See Also
- Five stocks we like better than NextPlat
- How to Capture the Benefits of Dividend Increases
- Semtech Stock Leads Industrial Semiconductors’ Comeback
- How to Know Which Cryptocurrency to Buy: A Guide for Investors
- Dogs of Tech: 3 Semiconductor Stocks Set for a 2025 Rebound
- The Role Economic Reports Play in a Successful Investment Strategy
- 2 Home Improvement Leaders Building Momentum for Upside
Receive News & Ratings for NextPlat Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for NextPlat and related companies with MarketBeat.com's FREE daily email newsletter.